Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (261-270 of 358) with videos related to

Pageof 36
Sort By:
Molecular Neurobiology|March 8, 2014
Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expressionMatthias Schmitz, Catharina Greis, Philipp Ottis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 13, 2018
Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob diseaseEirini Kanata, Ewa Golanska, Anna Villar-Piqué, et al.
Brain Pathology (Zurich, Switzerland)|December 9, 2025
Evidence for different seeding activities of misfolded tau in classical and rapidly progressive Alzheimer's diseaseMatthias Schmitz, Katrin Thüne, Anna-Lisa Fischer, et al.
Acta Neuropathologica Communications|January 22, 2026
Advancing prion diagnostics: full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluidSusana Da Silva Correia, Matthias Schmitz, Peter Hermann, et al.
Nature Protocols|October 14, 2016
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseasesMatthias Schmitz, Maria Cramm, Franc Llorens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 30, 2024
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin-1 causing cellular dysfunctions in vitro and in vivoAngela da Silva Correia, Matthias Schmitz, Anna-Lisa Fischer, et al.
Brain : a Journal of Neurology|September 5, 2023
Cross-seeding by prion protein inactivates TDP-43Stella A Polido, Cristiana Stuani, Aaron Voigt, et al.
Journal of Neurology|April 3, 2013
Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein geneDaniela Varges, Walter J Schulz-Schaeffer, Wiebke M Wemheuer, et al.
Frontiers in Neurology|March 29, 2017
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive FormsPaula Garcia-Esparcia, Irene López-González, Oriol Grau-Rivera, et al.
Alzheimer'S Research & Therapy|June 22, 2023
Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer's diseaseJanne Marieke Herden, Peter Hermann, Isabel Schmidt, et al.
Pageof 36

Showing results (261-270 of 358) with videos related to

Sort By:
Pageof 36
Molecular Neurobiology|March 8, 2014
Loss of prion protein leads to age-dependent behavioral abnormalities and changes in cytoskeletal protein expressionMatthias Schmitz, Catharina Greis, Philipp Ottis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 13, 2018
Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob diseaseEirini Kanata, Ewa Golanska, Anna Villar-Piqué, et al.
Brain Pathology (Zurich, Switzerland)|December 9, 2025
Evidence for different seeding activities of misfolded tau in classical and rapidly progressive Alzheimer's diseaseMatthias Schmitz, Katrin Thüne, Anna-Lisa Fischer, et al.
Acta Neuropathologica Communications|January 22, 2026
Advancing prion diagnostics: full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluidSusana Da Silva Correia, Matthias Schmitz, Peter Hermann, et al.
Nature Protocols|October 14, 2016
The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseasesMatthias Schmitz, Maria Cramm, Franc Llorens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 30, 2024
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin-1 causing cellular dysfunctions in vitro and in vivoAngela da Silva Correia, Matthias Schmitz, Anna-Lisa Fischer, et al.
Brain : a Journal of Neurology|September 5, 2023
Cross-seeding by prion protein inactivates TDP-43Stella A Polido, Cristiana Stuani, Aaron Voigt, et al.
Journal of Neurology|April 3, 2013
Spongiform encephalopathy in siblings with no evidence of protease-resistant prion protein or a mutation in the prion protein geneDaniela Varges, Walter J Schulz-Schaeffer, Wiebke M Wemheuer, et al.
Frontiers in Neurology|March 29, 2017
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive FormsPaula Garcia-Esparcia, Irene López-González, Oriol Grau-Rivera, et al.
Alzheimer'S Research & Therapy|June 22, 2023
Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer's diseaseJanne Marieke Herden, Peter Hermann, Isabel Schmidt, et al.
Pageof 36